RPL34B Antibody

Shipped with Ice Packs
In Stock

Description

Definition and Target Specificity

RPL34B is a component of the 60S ribosomal subunit in yeast, encoded by the RPL34B gene (UniProt ID: P40525). The RPL34B antibody specifically binds to this protein, enabling its identification in experimental settings. Ribosomal proteins like RPL34B are essential for translation, and their dysregulation can impact cellular growth and stress responses .

Experimental Applications

The RPL34B antibody is validated for:

  • Western Blot (WB): Detects ~13 kDa protein in S. cerevisiae lysates .

  • Immunohistochemistry (IHC): Localizes RPL34B in yeast cell sections with optimized antigen retrieval .

  • Immunofluorescence (IF): Visualizes ribosomal distribution in fixed cells .

Recommended dilutions:

  • WB: 1:500–1:2,000

  • IHC/IF: 1:50–1:500 .

Functional Insights

In yeast, RPL34B is critical for ribosome assembly and translational fidelity. Studies using RPL34B antibodies have revealed:

  • Genetic Interactions: RPL34B deletion mutants exhibit impaired growth under stress conditions, highlighting its role in cellular adaptation .

  • Structural Studies: Antibody-based assays have mapped RPL34B’s localization within the 60S subunit, aiding structural models of yeast ribosomes .

Comparative Analysis

While yeast RPL34B is well-characterized, its human homolog (RPL34) is implicated in oncogenesis. For example:

  • Human RPL34: Overexpressed in pancreatic, osteosarcoma, and esophageal cancers, where it drives proliferation via MAPK/p53 pathways .

  • Yeast RPL34B: No direct oncogenic role reported, but conserved structural motifs suggest evolutionary functional parallels .

Top Validated Antibodies

ProviderCatalog NumberClonalityApplications
CusabioCSB-PA334731XA01SVGPolyclonalWB, ELISA, ICC, IHC
Proteintech15179-1-APPolyclonalWB, IHC, IF/ICC, ELISA
GeneTexGTX34174PolyclonalWB, ELISA, ICC, IHC

Quality Control

  • Specificity: Proteintech’s 15179-1-AP antibody shows reactivity in HeLa, HepG2, and PC-3 cell lines .

  • Cross-Reactivity: Cusabio’s antibody is yeast-specific, avoiding false positives in mammalian systems .

Product Specs

Buffer
Preservative: 0.03% Proclin 300; Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 week lead time (made-to-order)
Synonyms
RPL34B antibody; At1g69620 antibody; F24J1.23 antibody; T6C23.18 antibody; 60S ribosomal protein L34-2 antibody
Target Names
RPL34B
Uniprot No.

Q&A

How do expression patterns of RPL34A and RPL34B differ during cell growth?

RPL34A and RPL34B show distinct expression patterns throughout different growth phases. Research has demonstrated that Rpl34b-FLAG rapidly increases to saturation level in the early log phase (around 1.5 hours of growth), while Rpl34a-FLAG shows low expression initially and only reaches maximal expression at early stationary phase (approximately 4.5 hours). This paralog-specific expression pattern suggests different functional roles, with Rpl34b-containing ribosomes potentially playing a crucial role during the lag phase, and Rpl34a-containing ribosomes becoming more important during log phase growth . These temporal differences in expression provide important insights into the specialized roles these paralogs may play in ribosome heterogeneity and cell physiology.

What species reactivity can be expected with RPL34 antibodies?

Most commercially available RPL34 antibodies have been tested and validated for reactivity with human, mouse, and rat samples. For example, the RPL34 antibody (15179-1-AP) from Proteintech shows confirmed reactivity with these three species in Western blot, immunohistochemistry, and immunofluorescence applications . When working with yeast models, researchers should note that while commercial antibodies target mammalian RPL34, they may or may not cross-react with yeast Rpl34 proteins due to evolutionary conservation. For yeast-specific studies, tagged versions of the protein (such as FLAG-tagged or HA-tagged constructs) are often used for detection and characterization as seen in paralog-specific expression studies .

What are the standard applications for RPL34B antibody in research?

RPL34 antibodies can be utilized in several standard research applications:

  • Western Blot (WB): Used for detecting RPL34 protein in cell or tissue lysates, with recommended dilutions typically ranging from 1:500 to 1:2000. Positive WB detection has been confirmed in multiple cell lines including HeLa, HepG2, PC-3, and in mouse liver tissue .

  • Immunohistochemistry (IHC): Used for localizing RPL34 in tissue sections, with recommended dilutions of 1:50 to 1:500. RPL34 antibodies have been successfully used for IHC in tissues such as mouse pancreas .

  • Immunofluorescence/Immunocytochemistry (IF/ICC): Used for visualizing RPL34 cellular localization, with recommended dilutions of 1:50 to 1:500. Positive detection has been reported in cell lines such as A431 and U-2 OS, revealing nucleolar and cytoplasmic localization patterns .

  • Chromatin Immunoprecipitation (ChIP): Although not directly mentioned for RPL34B, ChIP techniques are valuable for studying ribosomal proteins in the context of their association with actively transcribed genes .

How can deletion phenotypes of RPL34A and RPL34B be distinguished and characterized?

Distinguishing the phenotypic effects of RPL34A versus RPL34B deletion requires systematic analysis across multiple growth conditions. Research has demonstrated that deletion mutants of ribosomal protein paralogs form phenotypically distinct clusters, reflecting paralog-specific contributions to ribosome heterogeneity.

To characterize these differences:

  • Growth condition comparison: Culture deletion strains on different carbon sources (glucose, glycerol, oleic acid) at various temperatures (26°C, 30°C, 35°C) on solid media to measure colony size as a proxy for growth. In parallel, assess growth in liquid media under different stress conditions (oxidative, osmotic, high salt) .

  • Growth curve analysis: Monitor growth rates in liquid culture to identify phase-specific defects. For example, the distinct expression patterns of Rpl34a and Rpl34b during different growth phases suggest that their deletion may affect specific growth phases differently .

  • Clustering analysis: Perform hierarchical clustering of phenotypic data to identify patterns of similarity among different RP paralog deletions. This approach has revealed that specific paralog deletions cluster together, suggesting they may function within the same specialized ribosome populations .

Research findings show that rpl34bΔ strains have distinct phenotypes compared to rpl34aΔ strains, with more pronounced differences observed when cells are grown on oleic acid (YPO) medium compared to glucose (YPD) medium .

What methods are effective for studying paralog-specific incorporation of RPL34A and RPL34B into ribosomes?

To study the paralog-specific incorporation of RPL34A and RPL34B into ribosomes, researchers can employ several complementary approaches:

  • Epitope tagging and immunoprecipitation: Generate strains expressing epitope-tagged versions of Rpl34a and Rpl34b (e.g., FLAG-tagged, HA-tagged) to track their expression and incorporation into ribosomes throughout different growth phases. This approach has revealed temporal differences in paralog expression, with Rpl34b-FLAG rapidly increasing during early log phase while Rpl34a-FLAG reaches maximum expression only in early stationary phase .

  • Polysome profiling: Fractionate cell lysates on sucrose gradients to separate free ribosomal subunits, monosomes, and polysomes. Analyze the distribution of tagged Rpl34a and Rpl34b across these fractions to determine their association with actively translating ribosomes at different growth phases.

  • Ribosome footprinting: Use ribosome profiling to identify mRNAs being preferentially translated by ribosomes containing either Rpl34a or Rpl34b. This can reveal functional specialization in terms of the transcript populations translated by each paralog-containing ribosome.

  • Mass spectrometry: Employ quantitative mass spectrometry of purified ribosomes to determine the stoichiometry of Rpl34a versus Rpl34b incorporation under different growth conditions and cellular states.

These approaches can be combined to build a comprehensive understanding of how these paralogs contribute to ribosome heterogeneity and specialized function.

How does RPL34B deletion impact the translatome compared to RPL34A deletion?

The impact of RPL34 paralog deletions on the translatome (the set of actively translated mRNAs) has been studied through comparative analyses of rpl34aΔ and rpl34bΔ strains. Research findings indicate:

  • Distinct translatome profiles: The translatomes of rpl34bΔ cells are noticeably different from those of rpl34aΔ cells when grown in standard glucose medium (YPD), with these differences becoming more pronounced when cells are cultured in oleic acid medium (YPO) .

  • Differential translation of specific protein classes: Like other ribosomal protein paralog deletions (e.g., rpl12bΔ and rpl19bΔ), rpl34bΔ cells show reduced translation of peroxisome-associated proteins (such as Pex11, Pcs60, and Vps13) compared to wild-type and rpl34aΔ cells when grown on oleic acid medium. This suggests a specialized role for Rpl34b-containing ribosomes in the translation of specific mRNA subsets .

  • Compensatory mechanisms: Deletion of one paralog can trigger compensatory expression changes in the remaining paralog. For instance, higher expression of the remaining RPL34 paralog has been observed in deletion strains, potentially as a mechanism to mitigate the loss of function .

This differential impact on the translatome provides strong evidence for functional specialization between RPL34A and RPL34B, suggesting that ribosomes containing specific paralogs may be optimized for the translation of distinct mRNA subsets.

What is the optimal protocol for ChIP experiments involving RPL34B-associated factors?

While the search results don't specifically detail ChIP protocols for RPL34B, general ChIP methodologies for ribosomal proteins can be adapted. Based on ChIP protocols used for related studies :

  • Crosslinking and chromatin preparation:

    • Crosslink cells with 1% formaldehyde for 15-20 minutes at room temperature

    • Quench with glycine (final concentration 125mM)

    • Lyse cells and sonicate chromatin to fragments of 200-500bp

  • Immunoprecipitation:

    • For tagged RPL34B (e.g., protein A-tagged, HA-tagged, or Myc-tagged):

      • Use appropriate antibodies: rabbit IgG-agarose beads for protein A tags, anti-HA monoclonal antibody (MAb) 12CA5 followed by gamma-bind G Sepharose beads for HA tags, or anti-Myc MAb 9E10 for Myc tags

    • For untagged RPL34B:

      • Use a specific anti-RPL34 antibody validated for IP applications

    • Include appropriate negative controls (e.g., Cl-4b beads for protein A-tagged proteins)

  • Washing and elution:

    • Wash beads thoroughly to remove non-specific interactions

    • Elute bound complexes and reverse crosslinking

  • Analysis:

    • Perform PCR analysis targeting regions of interest, such as gene bodies containing introns

    • Quantify PCR products within the linear range of amplification

This protocol can be adapted to investigate whether RPL34B is recruited to specific genomic loci or associated with particular nascent transcripts, potentially revealing roles beyond its canonical function in the ribosome.

How should researchers design experiments to investigate differential functions of RPL34A and RPL34B in stress conditions?

To investigate differential functions of RPL34A and RPL34B under stress conditions, researchers should design experiments that systematically compare wild-type, single deletion (rpl34aΔ or rpl34bΔ), and complemented strains under various stressors. The following experimental design is recommended:

  • Strain preparation:

    • Generate single deletion strains (rpl34aΔ and rpl34bΔ)

    • Create complemented strains where the deleted paralog is reintroduced under its native promoter

    • Construct strains where one paralog is replaced with the other (e.g., RPL34A replaced with RPL34B and vice versa)

    • Include epitope-tagged versions for protein detection

  • Stress condition panel:

    Stress TypeConditions to TestMeasurements
    NutritionalDifferent carbon sources (glucose, glycerol, oleic acid); nitrogen limitationGrowth rate; colony size; metabolic activity
    TemperatureCold shock (15°C); heat shock (37°C, 42°C)Survival rate; growth recovery; heat shock protein induction
    ChemicalOxidative stress (H₂O₂); cell wall stress (calcofluor white); osmotic stress (high salt, sorbitol)Growth inhibition; stress response gene expression
    Translation stressCycloheximide (low dose); amino acid starvationPolysome profiles; global translation rates
  • Multi-omics analysis:

    • Transcriptomics: RNA-seq to compare gene expression profiles between strains under stress

    • Proteomics: Quantitative mass spectrometry to identify differentially translated proteins

    • Ribosome profiling: To determine which mRNAs are preferentially translated in each paralog deletion under stress

  • Protein-level analysis:

    • Western blotting to track expression levels of each paralog during stress response

    • Co-immunoprecipitation to identify stress-specific interaction partners

    • Immunofluorescence to monitor potential changes in subcellular localization during stress

Based on existing research showing differential expression patterns of RPL34A and RPL34B during growth phases , experiments should particularly focus on time-course analyses to capture paralog-specific functions that may be relevant only during specific phases of the stress response.

How can specificity for RPL34B versus RPL34A be ensured in experimental detection?

Ensuring specificity when detecting RPL34B versus RPL34A is challenging due to the high sequence similarity between these paralogs. To achieve paralog-specific detection:

  • Epitope tagging: The most reliable approach is to use epitope-tagged versions of each paralog (such as FLAG, HA, or Myc tags) in yeast models. This strategy has been successfully employed to show paralog-specific expression patterns during different growth phases . When designing tagged constructs:

    • Ensure the tag does not interfere with protein function by including controls that verify normal growth and ribosome assembly

    • Insert the tag at a position that minimizes functional disruption while maximizing accessibility for detection

  • Paralog-specific antibodies: For systems where genetic manipulation is not possible, attempt to develop antibodies against regions that differ between the paralogs:

    • Identify unique peptide sequences that distinguish RPL34A from RPL34B

    • Validate antibody specificity using single deletion strains (rpl34aΔ or rpl34bΔ) as controls

  • RNA-level detection: When protein-level discrimination is challenging, use nucleic acid-based methods:

    • Design paralog-specific PCR primers or hybridization probes targeting divergent regions

    • Employ quantitative RT-PCR with primers that uniquely amplify each paralog's mRNA

    • Use RNA-seq data analysis methods that can distinguish between highly similar transcripts

  • Genetic background controls: Always include appropriate genetic controls:

    • Single deletion strains (rpl34aΔ and rpl34bΔ) as negative controls

    • Wild-type strains expressing both paralogs as positive controls

These approaches, particularly when used in combination, can provide reliable discrimination between these closely related ribosomal protein paralogs.

What are the optimal fixation and antigen retrieval methods for RPL34 immunohistochemistry?

For optimal RPL34 immunohistochemistry results, specific fixation and antigen retrieval methods have been validated:

  • Fixation:

    • Standard formalin fixation followed by paraffin embedding (FFPE) is commonly used for tissues to be analyzed with RPL34 antibodies

    • For cell lines, paraformaldehyde (PFA) fixation (4%) followed by permeabilization with Triton X-100 has proven effective for immunofluorescent detection of RPL34

  • Antigen retrieval:

    • Primary recommendation: TE buffer at pH 9.0 has been validated for optimal antigen retrieval of RPL34 in tissue sections

    • Alternative method: Citrate buffer at pH 6.0 can also be used effectively as an alternative approach

  • Antibody concentration:

    • For IHC applications, dilutions of 1:50 to 1:500 are recommended, with the specific dilution depending on tissue type and detection method

    • Titration is advised for each new tissue type or experimental condition

  • Detection systems:

    • For brightfield IHC: Standard HRP-based detection systems with DAB substrate

    • For fluorescent detection: Appropriate secondary antibodies conjugated to fluorophores compatible with available imaging systems

These methods have been validated specifically for RPL34 detection, with successful staining demonstrated in tissues such as pancreas .

How should researchers optimize Western blot protocols for detecting low-abundance RPL34B?

Optimizing Western blot protocols for detecting low-abundance RPL34B requires attention to several critical parameters:

  • Sample preparation:

    • Use efficient lysis buffers containing protease inhibitors to prevent degradation

    • For ribosomal proteins, consider specialized extraction protocols that effectively solubilize ribosomes

    • Concentrate samples if necessary using TCA precipitation or similar methods

  • Gel electrophoresis:

    • Use high-percentage gels (15-18%) for optimal resolution of the low molecular weight RPL34 protein (13 kDa)

    • Load sufficient protein (typically 30-50 μg of total protein for cell lysates)

    • Include molecular weight markers that cover the relevant range (10-25 kDa)

  • Transfer conditions:

    • Optimize transfer for small proteins: use higher methanol concentration (up to 20%) in transfer buffer

    • Consider semi-dry transfer systems which can be more efficient for small proteins

    • Reduce transfer time to prevent small proteins from passing through the membrane

  • Blocking and antibody incubation:

    • Test different blocking agents (BSA vs. non-fat dry milk) to determine optimal signal-to-noise ratio

    • Use antibody dilutions within the recommended range (1:500-1:2000)

    • Extend primary antibody incubation time (overnight at 4°C) to maximize binding

  • Detection system:

    • Use high-sensitivity ECL substrates or fluorescent secondary antibodies

    • Consider signal amplification systems for very low abundance proteins

    • Optimize exposure times to capture weak signals without background

  • Controls:

    • Include positive controls (e.g., HeLa cells, HepG2 cells, or PC-3 cells)

    • Use deletion mutants as negative controls when possible

By optimizing each of these parameters, researchers can significantly improve the detection of low-abundance RPL34B in Western blot applications.

How does RPL34B contribute to the concept of specialized ribosomes in translational regulation?

RPL34B plays a significant role in the emerging concept of specialized ribosomes, which challenges the traditional view of ribosomes as homogeneous molecular machines. Based on recent research:

  • Paralog-specific ribosome populations: The existence of distinct phenotypes in rpl34aΔ versus rpl34bΔ strains provides evidence that ribosomes containing specific paralogs may have specialized functions. This is part of a broader pattern observed with other ribosomal protein paralogs, where deletion mutants form phenotypically distinct clusters reflecting paralog-specific ribosome heterogeneity .

  • Temporal specialization: The differential expression of RPL34A and RPL34B during different growth phases (with RPL34B predominantly expressed in early log phase and RPL34A reaching maximal expression only in early stationary phase) suggests temporal specialization of ribosome populations. This indicates that cells may modulate the composition of their ribosomes to optimize translation for specific physiological states .

  • Substrate specificity: Translatome analyses of rpl34aΔ and rpl34bΔ strains show differences in the translation of specific mRNA populations, particularly when cells are grown on oleic acid. Similar to other paralog deletions like rpl19bΔ, rpl34bΔ cells show reduced translation of peroxisome-associated proteins. This provides evidence that RPL34B-containing ribosomes may preferentially translate specific subsets of mRNAs .

  • Adaptive response: The observation that deletion of one paralog leads to increased expression of other ribosomal protein genes suggests a compensatory mechanism that may help maintain translational homeostasis. This reveals the plasticity of the translational machinery in response to perturbations .

These findings collectively support the model where RPL34B contributes to ribosome heterogeneity, allowing for specialized translation of specific mRNAs under different cellular conditions or developmental stages.

What experimental approaches can link RPL34B function to specific cellular pathways beyond translation?

To investigate RPL34B functions beyond its canonical role in translation, researchers can employ several experimental approaches:

  • Interactome analysis:

    • Perform immunoprecipitation followed by mass spectrometry to identify non-ribosomal interaction partners of RPL34B

    • Use proximity labeling techniques (BioID, APEX) to identify proteins in close proximity to RPL34B in living cells

    • Compare the interactome of RPL34A versus RPL34B to identify paralog-specific interactions

  • Genetic interaction screens:

    • Conduct synthetic genetic array (SGA) analysis with rpl34bΔ as the query strain to identify genes that show synthetic interactions

    • Compare genetic interaction profiles between rpl34aΔ and rpl34bΔ to identify pathways specifically linked to each paralog

    • Use chemical-genetic screens to identify compounds that differentially affect rpl34aΔ versus rpl34bΔ strains

  • Transcriptome and proteome profiling:

    • Perform RNA-seq and proteomics on deletion strains under various conditions to identify affected pathways

    • Focus on differentially expressed genes/proteins that are not directly related to translation

    • Use pathway enrichment analysis to identify cellular processes affected by RPL34B deletion

  • Subcellular localization studies:

    • Use fluorescently tagged RPL34B to track its localization under different conditions

    • Look for non-ribosomal localization patterns that might suggest extraribosomal functions

    • Employ techniques like FRAP (Fluorescence Recovery After Photobleaching) to study the dynamics of RPL34B trafficking between cellular compartments

  • Chromatin association studies:

    • Use ChIP-seq to investigate whether RPL34B associates with specific genomic regions

    • Compare chromatin association patterns between RPL34A and RPL34B

    • Investigate potential roles in transcriptional regulation similar to other ribosomal proteins that have been found to have dual functions

Research has already shown that ribosomal proteins can have extraribosomal functions in processes such as DNA repair, transcriptional regulation, and stress response. Using these approaches may reveal similar non-canonical roles for RPL34B.

How can RPL34B research contribute to understanding evolutionary diversification of ribosomal proteins?

RPL34B research provides valuable insights into the evolutionary diversification of ribosomal proteins, particularly through the lens of gene duplication and functional specialization:

  • Paralog divergence analysis:

    • Comparative sequence analysis of RPL34 across species reveals conservation patterns and diversification rates

    • The presence of two paralogs (RPL34A and RPL34B) in yeast represents a common evolutionary pattern in eukaryotes, where gene duplication followed by subfunctionalization or neofunctionalization has occurred

    • Different expression patterns of RPL34A and RPL34B during growth phases suggest functional divergence after duplication

  • Functional specialization evidence:

    • The distinct phenotypes observed in rpl34aΔ versus rpl34bΔ strains indicate that these paralogs have evolved specialized functions

    • Translatome differences between deletion strains provide molecular evidence for functional divergence

    • This supports the model where gene duplication provides raw material for evolutionary innovation in ribosome function

  • Cross-species comparative approaches:

    • Comparing the functions of RPL34 homologs across evolutionary diverse species (from yeast to humans) can reveal conserved and species-specific roles

    • The observation that human RPL34 antibodies can potentially recognize the yeast protein suggests structural conservation despite functional divergence

    • Investigation of whether the specialized functions observed in yeast paralogs are conserved in other organisms with single RPL34 genes can provide insights into the evolutionary trajectory of ribosomal protein functions

  • Evolutionary rate analysis:

    • Comparing evolutionary rates between RPL34A and RPL34B can reveal whether one paralog is evolving under different selective pressures than the other

    • Regions of the proteins showing different rates of evolution may correspond to sites important for paralog-specific functions

By systematically investigating these aspects of RPL34A and RPL34B, researchers can contribute to the broader understanding of how gene duplication and subsequent functional divergence contribute to the evolution of complex cellular systems like the ribosome.

How can CRISPR-Cas9 technology be applied to study RPL34B function across different model systems?

CRISPR-Cas9 technology offers powerful approaches to study RPL34B function across diverse model systems, enabling precise genetic manipulations that were previously challenging:

  • Paralog-specific knockout strategies:

    • Design guide RNAs targeting unique regions of RPL34B to create clean knockout models

    • For organisms with high sequence similarity between paralogs, employ the CRISPR base editing approach to introduce paralog-specific mutations without double-strand breaks

    • Generate conditional knockout systems using inducible CRISPR systems (e.g., Tet-inducible Cas9) to study essential ribosomal genes

  • Tagging and reporter systems:

    • Use CRISPR-mediated homology-directed repair to introduce epitope tags or fluorescent reporters at the endogenous RPL34B locus

    • Create translational fusions that maintain the native regulatory elements

    • Implement split fluorescent protein systems to study RPL34B interactions with specific partners in living cells

  • Precise mutations and domain analysis:

    • Introduce specific point mutations to study structure-function relationships

    • Create chimeric constructs swapping domains between RPL34A and RPL34B to identify regions responsible for paralog-specific functions

    • Engineer systems where RPL34B expression can be rapidly depleted (e.g., auxin-inducible degron tags) to study acute effects of protein loss

  • Cross-species applications:

    Model SystemCRISPR ApplicationResearch Question
    Yeast (S. cerevisiae)Base editing for paralog discriminationParalog-specific functions in ribosome heterogeneity
    Mammalian cell linesCRISPRi for controlled downregulationDosage-dependent functions of RPL34
    ZebrafishTissue-specific CRISPR activationDevelopmental roles in specific tissues
    DrosophilaCRISPR screening with RPL34 sgRNAsGenetic interactions in different developmental contexts
    MouseConditional tissue-specific knockoutPhysiological roles in complex tissues
  • Multiplexed approaches:

    • Apply CRISPR screening to identify genetic interactions with RPL34B

    • Combine CRISPR perturbations with single-cell RNA-seq to reveal cell type-specific functions

    • Use CRISPR-mediated simultaneous manipulation of multiple ribosomal protein genes to study combinatorial effects

These CRISPR-based approaches provide unprecedented precision for dissecting RPL34B function across phylogeny, offering new insights into both conserved and species-specific roles of this ribosomal protein.

What are the considerations for using RPL34B as a marker in cancer research?

While RPL34B itself is primarily studied in yeast, its human homolog RPL34 has implications in cancer research that should be considered:

  • Expression pattern analysis:

    • Several ribosomal proteins, including RPL34, show altered expression in various cancer types

    • Researchers should evaluate RPL34 expression across cancer databases (e.g., TCGA, CCLE) to identify cancer types with significant expression changes

    • Compare expression in tumor versus matched normal tissues to establish baseline differences

  • Prognostic value assessment:

    • Investigate correlations between RPL34 expression levels and patient survival or disease progression

    • Perform multivariate analysis to determine if RPL34 provides independent prognostic information

    • Consider tissue-specific variation in RPL34 as a prognostic marker, as its utility may vary by cancer type

  • Technical considerations for detection:

    • When using RPL34 antibodies for cancer tissue staining, optimize protocols specific to each tissue type

    • For immunohistochemistry applications, recommended dilutions range from 1:50 to 1:500, with antigen retrieval in TE buffer (pH 9.0) or citrate buffer (pH 6.0)

    • In Western blot applications, RPL34 appears at approximately 13 kDa and has been successfully detected in various cancer cell lines including HeLa, HepG2, and PC-3

  • Functional studies in cancer models:

    • Investigate whether RPL34 alterations are drivers or passengers in oncogenesis

    • Study the impact of RPL34 manipulation on cancer cell proliferation, migration, and response to therapy

    • Explore potential extraribosomal functions of RPL34 that might contribute to cancer phenotypes

  • Therapeutic targeting considerations:

    • Evaluate RPL34 as a potential therapeutic target, particularly in cancers with elevated expression

    • Consider the essential nature of ribosomal proteins when designing targeting strategies

    • Explore synthetic lethal approaches that may selectively affect cancer cells with altered RPL34 expression

These considerations provide a framework for incorporating RPL34 studies into cancer research, while acknowledging the challenges and opportunities presented by this ribosomal protein as a potential biomarker or therapeutic target.

What emerging technologies will advance our understanding of RPL34B function in specialized ribosomes?

Several cutting-edge technologies are poised to transform our understanding of RPL34B's role in specialized ribosomes:

  • Single-molecule imaging approaches:

    • Single-molecule fluorescence resonance energy transfer (smFRET) can reveal conformational changes in ribosomes containing either RPL34A or RPL34B

    • Super-resolution microscopy techniques like STORM or PALM can visualize the spatial distribution of different paralog-containing ribosomes within the cell

    • These approaches can help determine if RPL34A and RPL34B-containing ribosomes localize to distinct subcellular compartments

  • Cryo-electron microscopy advances:

    • High-resolution cryo-EM structures of ribosomes containing either RPL34A or RPL34B can reveal subtle structural differences

    • Time-resolved cryo-EM can capture different conformational states during translation

    • Structural studies may identify unique interaction surfaces on each paralog that could explain functional specialization

  • Single-cell multi-omics integration:

    • Single-cell transcriptomics combined with single-cell proteomics can reveal cell-to-cell variation in RPL34A versus RPL34B expression

    • Spatial transcriptomics techniques can map the distribution of ribosomes containing different paralogs within tissues

    • Integration of multiple single-cell data types can reveal correlations between RPL34 paralog expression and cellular states

  • Ribosome profiling advancements:

    • Selective ribosome profiling using tagged versions of RPL34A and RPL34B can identify mRNAs preferentially translated by each paralog-containing ribosome

    • Development of methods to capture ribosome-associated nascent chains can link RPL34 paralogs to the synthesis of specific proteins

    • Integration with structural data through techniques like selective 2'-hydroxyl acylation analyzed by primer extension (SHAPE) can provide insights into how RPL34 paralogs influence ribosome structure and function

These emerging technologies, particularly when used in combination, promise to provide unprecedented insights into the specialized functions of RPL34 paralogs in ribosome heterogeneity and translational regulation.

How can multi-omics approaches be integrated to comprehensively study RPL34B function?

Integrating multiple omics approaches creates a comprehensive framework for understanding RPL34B function:

  • Multi-level data collection strategy:

    Omics ApproachTechnical PlatformRPL34B-Specific Application
    GenomicsWhole genome sequencingIdentify natural variants and regulatory elements
    TranscriptomicsRNA-seq, nascent RNA-seqCompare expression regulation of RPL34A vs RPL34B
    ProteomicsMass spectrometry, BioIDIdentify RPL34B-specific interaction partners
    TranslatomicsRibosome profilingDetermine mRNAs preferentially translated by RPL34B-containing ribosomes
    MetabolomicsLC-MS/MSIdentify metabolic pathways affected by RPL34B deletion
    InteractomicsIP-MS, crosslinkingMap the extended interaction network of RPL34B
  • Comparative experimental design:

    • Analyze wild-type, rpl34aΔ, and rpl34bΔ strains in parallel across all omics platforms

    • Include time-course measurements to capture dynamic changes during different growth phases

    • Test multiple stress conditions to identify condition-specific functions

  • Data integration approaches:

    • Apply network-based integration to connect findings across different omics layers

    • Use machine learning to identify patterns and predictive features across datasets

    • Employ systems biology modeling to contextualize RPL34B function within cellular pathways

  • Validation strategy:

    • Select key findings from integrated analysis for targeted experimental validation

    • Design experiments that directly test predictions from multi-omics integration

    • Iterate between computational prediction and experimental validation

This integrated multi-omics approach provides a systems-level understanding of RPL34B function, revealing not only its direct roles but also its position within the broader cellular network. The comparative analysis between paralogs is particularly powerful for identifying specialized functions that might be missed by single-omics approaches.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.